The company is seeking approval for the drug as a treatment for herpetic keratitis. The federal agency expects to complete its review by late fall, according to Sirion Therapeutics.
vision-research.eu - The Gateway to European Vision Research
You are here: vision-research.eu » News » Newsdetails: